Galapagos NV is a biotechnology company focused on the discovery and development of innovative treatments for a variety of diseases, particularly those affecting the immune system and the central nervous system

The company leverages its proprietary target discovery platform and extensive drug development expertise to create therapeutics that aim to address significant unmet medical needs. With a commitment to advancing science through collaboration and research, Galapagos-NV works towards bringing novel therapies from laboratory to clinic, ultimately striving to improve patient outcomes and quality of life.